Regulation for in vitro diagnostics (IVDs) in Europe moves into as bureaucracy swells the draft directive
This article was originally published in Clinica
A pan-European system for the regulation of in vitro diagnostics (IVDs) is finally in sight. In mid-June the European Parliament will give the draft IVD directive, which European Union ministers finally agreed last November, its second reading. Consultant Maurizio Suppo takes a look at the proposals which will change the way IVD manufacturers do business in Europe.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.